Lundbeck Czech Republic

Last updated: 13.02.2014

Address: Bozdechova 7, 150 00 Prague 5,Czech Republic

Tel: +420 2 2527 5600


Company description

Our vision is to become a world leader in psychiatry and neurology.

Our mission is to improve the quality of life of people suffering from psychiatric and neurological disorders.

Imaginative – Dare to be different

‘Imaginative’ underlines a need to dare to be different. Lundbeck believes in the necessity of being open to new knowledge and alternative solutions. This is the cornerstone of Lundbeck’s value chain, from research and development to production, marketing and sales.

Passionate – Never give up

‘Passionate’ refers to a long-standing tradition of never giving up. Lundbeck has met with setbacks – and will meet them again – in the effort to find new treatments for CNS disorders.

Responsible – Do the right thing

‘Responsible’ means that Lundbeck employees are expected to do the right thing and act responsibly towards colleagues, the environment and the external community

Products and services

Lundbeck markets a number of different pharmaceuticals for the treatment of brain disorders. The most recently launched compounds include: Cipralex/Lexapro® (depression), Ebixa® (Alzheimer’s disease), Azilect® (Parkinson’s disease), Xenazine® (chorea associated with Huntington’s disease), Sabril® (epilepsy), Sycrest® (bipolar disorder) and OnfiTM (Lennox-Gastaut syndrome).



We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here